Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Leerink Swann
Biotech
SVB buys Leerink for $280M, boosting its life sciences business
Silicon Valley Bank parent SVB is buying Leerink to create a new company with a "complete capital markets offering."
Phil Taylor
Nov 14, 2018 9:54am
Celgene’s R&D success ‘somewhat disappointing’
May 25, 2018 10:23am
Leerink talks up Gilead’s R&D shift from virology to NASH, cancer remains tricky proposition
May 30, 2017 7:22am
Despite deaths and trial halts, Leerink sees Juno positives
Feb 16, 2017 4:36am
